Related Experiment Videos
Bronchoplastic resection for non-small-cell lung cancer
C Müller1, C Schinkel, H Hoffmann
1Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilians University, München, Germany.
The Thoracic and Cardiovascular Surgeon
|October 1, 1996
Summary
Bronchoplastic resections are a safe option for central non-small-cell lung cancer (NSCLC) surgery. This study found low complication rates and high rates of complete resection in 102 patients undergoing these procedures.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
Background:
- Non-small-cell lung cancer (NSCLC) often requires complex surgical approaches.
- Central NSCLC tumors may necessitate lung-sparing procedures to preserve pulmonary function.
Purpose of the Study:
- To evaluate the safety and efficacy of bronchoplastic procedures in treating central NSCLC.
- To assess complication rates and oncologic outcomes following bronchoplasty for NSCLC.
Main Methods:
- Retrospective analysis of 1478 lung cancer surgeries over 12 years.
- Detailed review of 102 bronchoplastic resections, including sleeve resections, wedge resections, and tracheal bifurcation resections.
- Analysis of surgical outcomes, including atelectasis, anastomotic dehiscence, local resection rates, and 30-day mortality.
Main Results:
- 102 (6.9%) bronchoplastic resections were performed, including lobectomies, bilobectomies, and pneumonectomies.
- Complication rates were low: 6% atelectasis and 4% anastomotic dehiscence.
- High rates of local complete resection (81%) and a 30-day mortality of 4% were observed.
Conclusions:
- Bronchoplastic procedures are a safe and effective therapeutic option for central NSCLC.
- These lung-sparing techniques achieve favorable oncologic outcomes with acceptable morbidity.
- Bronchoplasty should be considered in the surgical management of selected central NSCLC cases.